Though asbestos company owners often argue that low level exposure to their contaminated products cannot lead to the rare form of cancer known as malignant mesothelioma, a recent study is contradicting their assertions, as it concludes that those with minimal exposure are actually at a greater risk of being diagnosed with the disease than is
Did you ever imagine that Darwin’s theory of evolution could ever be applied to mesothelioma research? It’s a real possibility, as cancer researchers from the United Kingdom begin to study how cancer cells grow and evolve to survive, and specifically how they change to evade the effects of the body’s immune system.
Mesothelioma is such a lethal condition, and so challenging to treat, that cancer researchers are being forced to think outside of the box to find both better medications and better ways to deliver those medications. Scientists from MIT’s Koch Center for Integrative Cancer Research are doing both, creating a specially-formulated medication that instructs the lung’s
Malignant mesothelioma is among the rarest forms of cancer. It is also one of the most difficult to treat. Mesothelioma continues to be considered a fatal diagnosis, despite strides that have been made in improving longevity for many of those identified as having the disease. It is the challenge of treating the condition, as well
CAR T-cell therapy is a new type of immunotherapy for cancer treatment that might benefit mesothelioma patients. Clinical trials represent a unique opportunity for patients who qualify to access innovative medicine with great promise. CAR T-cell therapy modifies a patient’s immune system cells and has already shown good results with bone marrow and blood cancers.
The fiberglass connection to mesothelioma is a concern because it has replaced asbestos in most insulation. While not nearly as dangerous to human health, glass fibers can still cause harm. Insulators working today might also come in contact with old asbestos insulation, which can lead to mesothelioma. What Is Fiberglass? Fiberglass is a synthetic mineral
Atezolizumab (Tecentriq) is an immunotherapy drug currently under study in clinical trials to treat mesothelioma. It is already used to treat bladder, breast, and lung cancers. If you are interested in getting involved in a trial with atezolizumab, talk to your specialists to determine if you qualify for clinical trials. What Is Atezolizumab? Atezolizumab is
Anetumab ravtansine clinical trials are currently testing the effectiveness and the safety of this experimental cancer and mesothelioma drug made by Bayer. Anetumab revtansine selectively targets certain types of cancer cells to deliver a cytotoxic drug directly to them, minimizing harm to healthy cells. These trials provide later-stage patients with another option for treatment. What
Mesothelioma durvalumab clinical trials are testing the safety and effectiveness of this immunotherapy drug for pleural mesothelioma patients. This is also a targeted therapy that may only work for cancers that express a specific protein. The FDA has approved durvalumab to treat bladder cancer and non-small cell lung cancer. What Is Durvalumab? Durvalumab is made
Opdivo (nivolumab) and Yervoy (ipilimumab) are immunotherapy drugs approved to treat pleural mesothelioma. The National Comprehensive Cancer Network (NCCN) recommends that physicians use a combination of both agents for treating mesothelioma that has progressed through an initial first-line treatment. What Is Nivolumab and Ipilimumab Combination Mesothelioma Treatment? In 2020, the U.S. Food and Drug Administration